To compare two drugs for reduction of propofol injection pain

Randomised controlled trial to compare cisatracurium versus 2%lignocaine preservative free (xylocard) pretreatment with tourniquet to reduce propofol injection pain

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/06/034333

Enrollment

Registered

2021-06-22

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Cisatracurium: In reduction of propofol injection pain Control Intervention1: Preservative free 2%lignocaine(xylocard): In reduction of propofol injection pain

Eligibility

Inclusion criteria

Inclusion criteria: Patients posted for elective surgery

Exclusion criteria

Exclusion criteria: Patient refusal Allergy to propofol, egg History of cardiovascular, respiratory dysfunction History of difficult intubation

Design outcomes

Primary

Measure	Time frame
Efficacy of cisatracurium with 2% xylocard pretreatment to reduce propofol injection painTimepoint: Single	—

Secondary

Measure	Time frame
Any adverse effects (nausea , vomiting , muscle paralysis, diplopia, anaphylaxis) of cisatracurium and 2%xylocaine preservative free during study cisatracuriumTimepoint: Single;Any adverse effects,(nausea, vomiting, muscle paralysis, diplopia, anaphylaxis) of both these drugsTimepoint: Single	—

Countries

India

Contacts

Public ContactBALWINDERJIT SINGH

Panjab institute of medical sciences Jalandhar

drbalwinder2000@yahoo.co.in9814087951

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026